However, subsequent analysis of additional subjects suggests that D679N represents a rare neutral EPHB2 polymorphism, since the variant allele was observed at similar frequencies in patients with colorectal cancer (11 out of 1133) and population-matched controls (11 out of 1160). This evidence concerns the gene EPHB2 and colorectal cancer.